News Highlights:


Great article by WIRED about Biotia’s work battling HAIs using sequencing-based tests:

Biotia is honored to join the Digital Health Breakthrough Network! We look forward to both building relationships in the NYC healthcare system, and working with the HITLAB and NYCEDC's team to streamline and enhance our implementation. For more details, please read the NYCEDC press release.


Biotia is proud to commit with more than 100 organizations against the global threat of antimicrobial resistance, at the  “Global AMR Challenge” launched yesterday at the CDC.  For more information, please visit the CDC article.

Biotia, featured as one of the five Cornell Tech companies to watch by Tech:NYC! Congratulations to Crater, Cabinet, OnSiteIQ and Tatch as well! For more detail, please check it out the full article.

February 2018:

With the flu still around, watch out for highly touched surfaces in your workplace... Our co-founder Dr. Chris Mason explains to CBS News how shotgun sequencing and computational analysis can help effectively for tracking the flu.

September 2017:

Our study related to the microbiome of ambulances is now available in open access in the journal Microbiome. This nationwide project was led by our CEO/co-founder, Dr. Niamh O'Hara, with contributions from Biotia co-founders, Dr. Chris Mason, and Dr. Rachid Ounit. It is the only study of its kind, showing that metagenomics can be a powerful method to characterize the microbial ecology of pre-hospital ambulance settings! Please read our publication here.

May 2017:

GenomeWeb, a leading online media that tracks innovations in genomics, genetics and bioinformatics, wrote about us!  Check it out the article here.

Cornell Chronicle wrote a cover article about us and our collaborations with academic institutions.

Twitter Feed: